The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

16 articles for DG Smith


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery and structure-activity relationship of 1,3-cyclohexyl amide derivatives as novel mGluR5 negative allosteric modulators.EBI
Lundbeck Research Usa
The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives.EBI
Smithkline Beecham Pharmaceuticals
 
Non thiazolidinedione antihyperglycaemic agents. 2: α-Carbon substituted β-phenylpropanoic acids1EBI
TBA
 
Non thiazolidinedione antihyperglycaemic agents. 1: α-Heteroatom substituted β-phenylpropanoic acidsEBI
TBA
Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.EBI
Smithkline Beecham Pharmaceuticals
Selective inhibition of low affinity IgE receptor (CD23) processing.EBI
Smithkline Beecham Pharmaceuticals
Hydroxamate-based inhibitors of low affinity IgE receptor (CD23) processing.EBI
Smithkline Beecham Pharmaceuticals
Inhibition of cyclic nucleotide phosphodiesterase by derivatives of 1,3-bis(cyclopropylmethyl)xanthine.EBI
Smithkline Beecham Pharmaceuticals
Histone deacetylase inhibitors and compositions and methods of use thereofBDB
Chdi Foundation
Histone demethylase inhibitorsBDB
Celgene Quanticel Research
Cyclopropanamine compound and use thereofBDB
Takeda Pharmaceutical
Compounds and methods for inhibiting JAKBDB
Astrazeneca
Quinazoline derivatives, compositions thereof, and use as pharmaceuticalsBDB
Shanghai Fochon Pharmaceutical
Carbazole carboxamide compoundsBDB
Bristol-Myers Squibb
Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones.BDB
Upjohn
Selective non-nucleoside HIV-1 reverse transcriptase inhibitors. New 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds with anti-HIV-1 activity.BDB
Boehringer Mannheim